29 related articles for article (PubMed ID: 19671415)
1. Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway.
Gao M; Liu L; Zhang X; Li Z; Zhang M
Environ Toxicol Pharmacol; 2021 Jul; 85():103639. PubMed ID: 33771682
[TBL] [Abstract][Full Text] [Related]
2. Reversal of anticancer multidrug resistance by the ardeemins.
Chou TC; Depew KM; Zheng YH; Safer ML; Chan D; Helfrich B; Zatorska D; Zatorski A; Bornmann W; Danishefsky SJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8369-74. PubMed ID: 9653193
[TBL] [Abstract][Full Text] [Related]
3. Total aglycones from Marsdenia tenacissima increases antitumor efficacy of paclitaxel in nude mice.
Zhu RJ; Shen XL; Dai LL; Ai XY; Tian RH; Tang R; Hu YJ
Molecules; 2014 Sep; 19(9):13965-75. PubMed ID: 25197933
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of ME2303, a fluorine-containing anthracycline, against human tumors implanted in nude mice.
Tsuruo T; Sato S; Yusa K
Jpn J Cancer Res; 1989 Jul; 80(7):686-9. PubMed ID: 2507492
[TBL] [Abstract][Full Text] [Related]
5. Experimental Research on the Antitumor Effect of Human Gastric Cancer Cells Transplanted in Nude Mice Based on Deep Learning Combined with Spleen-Invigorating Chinese Medicine.
Ai K; Yuan D; Zheng J
Comput Math Methods Med; 2022; 2022():3010901. PubMed ID: 35190750
[TBL] [Abstract][Full Text] [Related]
6. Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.
Braslawsky GR; Kadow K; Knipe J; McGoff K; Edson M; Kaneko T; Greenfield RS
Cancer Immunol Immunother; 1991; 33(6):367-74. PubMed ID: 1878890
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice.
Ehrke MJ; Verstovsek S; Ujházy P; Meer JM; Eppolito C; Maccubbin DL; Mihich E
Cancer Immunol Immunother; 1998 Feb; 45(6):287-98. PubMed ID: 9490198
[TBL] [Abstract][Full Text] [Related]
8. Studies on the Incompatibility between
Liu W; Wei L; Kanai Y; He X
Evid Based Complement Alternat Med; 2021; 2021():8351717. PubMed ID: 34650616
[No Abstract] [Full Text] [Related]
9. Effect of Compound Zhebei Granule () combined with chemotherapy on surface markers of leukemia stem cell in patients with acute myeloid leukemia.
Wang J; Lai ZL; Chen XY; Li DY; Zhang YY; Ma W; Chu YT; Shi FQ; Yang L; Hou L
Chin J Integr Med; 2016 Jun; 22(6):438-44. PubMed ID: 26666761
[TBL] [Abstract][Full Text] [Related]
10. [Research progress in the reversion of traditional Chinese medicine on multidrug resistance of tumor].
Song XR; Hou SX
Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1300-4. PubMed ID: 16245913
[TBL] [Abstract][Full Text] [Related]
11. Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine.
Zhao HD; Xie HJ; Li J; Ren CP; Chen YX
Chin J Integr Med; 2018 Jun; 24(6):474-480. PubMed ID: 29860581
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Compound Zhebei Granule plus doxorubicin on mdr 1 gene expression in nude mice with K562/A02 tumor xenografts].
Zheng Z; Chen J; Li DY; Chen XY
Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):758-62. PubMed ID: 19671415
[TBL] [Abstract][Full Text] [Related]
13. [Effects of compound Zhe-Bei granule (CZBG) combined with doxorubicin on expression of membrane transport proteins in K562/A02 cell xenografts].
Li DY; Zheng Z; Hou L; Jiang M; Dong Q; Tian SD; Ma W; Chen J; Wang J; Chen XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):45-8. PubMed ID: 20137116
[TBL] [Abstract][Full Text] [Related]
14. [Effect of compound Zhe-Bei granule (CZBG) combined with doxorubicin on cell apoptosis and expression of related proteins in K562/A02 multidrug resistance tumor xenografts in mice].
Chen XY; Zheng Z; Chen J; Li DY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1439-42. PubMed ID: 20030922
[TBL] [Abstract][Full Text] [Related]
15. MDR reversal activity of bromotetrandrine in vitro and in vivo.
Cheng J; Wang JQ; Chen BA; Gao F; Xu WL; Shen HL; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Song HH; Bao W; Sun Q; Dai YY; Sun XC; Cheng HY; Deng YX; Li GH; Chen NN; Liu LJ; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1183-91. PubMed ID: 19840447
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]